by webmaster | Nov 21, 2025 | Gen Med Blog
South Africa’s healthcare system stands at a pivotal moment. As it aims to strengthen access to affordable, quality medicines for all citizens, regulatory reform has become a cornerstone of national health discourse. Regulatory bodies such as the South African Health...
by webmaster | Nov 21, 2025 | Gen Med Blog
As South Africa expands the use of generic and biosimilar medicines within its healthcare system, the role of healthcare providers in patient education has never been more critical. Despite well-established regulatory standards and robust clinical data supporting the...
by webmaster | Nov 21, 2025 | Gen Med Blog
Efficient regulatory processes are essential to ensuring that safe, effective, and affordable medicines reach patients without unnecessary delays. In South Africa, the South African Health Products Regulatory Authority (SAHPRA) plays a central role in the evaluation...
by webmaster | Nov 21, 2025 | Gen Med Blog
South Africa faces a growing burden of chronic diseases, including diabetes, hypertension, cancer, HIV/AIDS, and rheumatoid arthritis. As treatment regimens become more complex and long-term adherence becomes essential, access to safe, effective, and affordable...
by webmaster | Nov 21, 2025 | Gen Med Blog
Biosimilars and generics both play an important role in expanding access to affordable medicines, but they differ significantly in structure, manufacturing, and regulatory approval. Understanding these distinctions is essential for healthcare professionals,...
by webmaster | Oct 10, 2025 | Gen Med Blog
As South Africa navigates the complexities of medicine access, ranging from regulatory delays and affordability to supply chain disruptions and governance, there is growing consensus that sustainable improvement requires system-wide coordination. This final article in...
